Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diegohave created a rapid diagnostic technology that detects SARS-CoV-2, the ...

Schematic illustration of nucleic acid detection by the conventional CRISPR assay and the asymmetric CRISPR assay. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-43389-7 Changchun Liu, ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

Smartphone-based optical imaging and sensing devices are among the next-generation biosensors that have shown great potential to transform the field of point-of-care (POC) diagnostics. With the rapid ...

CRISPR-Cas systems, defense systems in bacteria, have become a plentiful source of technologies for molecular diagnostics. Researchers have now expanded this extensive toolbox further. Their novel ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized solutions across biotech.

Overview of CRISPR/Cas system-based tumor molecular diagnostic strategies, including variant gene, protein, and liquid biopsy marker assays and in situ molecular analysis. The CRISPR/Cas system, known ...

BRISBANE, Calif.--(BUSINESS WIRE)--Mammoth Biosciences, the biotech company leveraging the diversity of life to build the next generation of CRISPR products to cure and detect disease, today announced ...

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...